This biology may be important in comparing modalities of TNFα inhibitors as the drugs targeting soluble TNF receptors (instead of anti‐TNF antibodies; i.e., etanercept and onercept, saw no efficacy in clinical trials of CD).21 The gene discussed is TNF; the disease is Cowden disease.